# Swiss pharmaceutical giant Roche said on Thursday it had agreed to acquire U.S.-based digital pathology and AI-powered technology firm PathAI.

*biotech · news · 2026-05-07 · MarketScreener*

## Key points

- Roche will acquire PathAI for $750 million upfront plus up to $300 million in milestone payments.
- PathAI will become part of Roche's diagnostics division after the deal closes in the second half of 2026.
- The acquisition follows a partnership expanded in 2024 to co-develop AI-enabled companion diagnostic algorithms.
- Roche aims to use PathAI to fully automate digital pathology workflows with advanced AI technology.

**Companies:** Roche, PathAI
**Countries:** Switzerland, United States

[Read the full story on MarketScreener](https://www.marketscreener.com/news/switzerland-s-roche-agrees-to-acquire-us-based-pathai-ce7f58d3d888f427)

---

Canonical: https://newsio.io/n/3ca3eb4f-6784-45d3-ae5e-4b9b5c5bd56f/swiss-pharmaceutical-giant-roche-said-on-thursday-it-had-agreed-to-acquire-u-s-b
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works